• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌化疗药物的药代动力学。

Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy.

机构信息

Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, Pennsylvania 19140, USA.

出版信息

Adv Exp Med Biol. 2010;678:124-32. doi: 10.1007/978-1-4419-6306-2_16.

DOI:10.1007/978-1-4419-6306-2_16
PMID:20738014
Abstract

Pharmacokinetics of anticancer drugs used in breast cancer therapy are well established. This chapter reviews preclinical and clinical pharmacokinetics of the following drugs: cyclophosphamide, docetaxel, doxorubicin, 5-fluorouracil, methotrexate and tamoxifen. The absorption, distribution, metabolism and elimination of drugs are discussed in the context of breast cancer. The effect of age and menopause status on drug pharmacokinetics is evaluated. The important role of pharmacokinetic-pharmacodynamic modeling in understanding the phenomenon of chemo fog, memory deficit in breast cancer chemotherapy, is explored.

摘要

用于乳腺癌治疗的抗癌药物的药代动力学已得到充分确立。本章综述了以下药物的临床前和临床药代动力学:环磷酰胺、多西他赛、多柔比星、5-氟尿嘧啶、甲氨蝶呤和他莫昔芬。讨论了药物在乳腺癌中的吸收、分布、代谢和消除。评估了年龄和绝经状态对药物药代动力学的影响。探讨了药代动力学-药效学建模在理解化疗雾、乳腺癌化疗记忆缺陷现象中的重要作用。

相似文献

1
Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy.乳腺癌化疗药物的药代动力学。
Adv Exp Med Biol. 2010;678:124-32. doi: 10.1007/978-1-4419-6306-2_16.
2
Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.淋巴结阳性乳腺癌女性的辅助全身治疗。乳腺癌护理与治疗临床实践指南指导委员会。
CMAJ. 1998 Feb 10;158 Suppl 3:S52-64.
3
Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
Eur J Cancer (1965). 1980;Suppl 1:113-7.
4
Clinical pharmacokinetics of drugs used in the treatment of breast cancer.
Clin Pharmacokinet. 1988 Sep;15(3):180-93. doi: 10.2165/00003088-198815030-00003.
5
Pharmacological breast cancer therapy (review).乳腺癌的药物治疗(综述)
Int J Oncol. 2005 Nov;27(5):1341-4.
6
Adjuvant systemic therapy for resectable breast cancer.
J Clin Oncol. 1985 Feb;3(2):259-75. doi: 10.1200/JCO.1985.3.2.259.
7
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.促性腺激素释放激素类似物曲普瑞林对乳腺癌绝经前妇女化疗诱导早绝经发生的影响:一项随机试验。
JAMA. 2011 Jul 20;306(3):269-76. doi: 10.1001/jama.2011.991.
8
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.序贯或同步使用蒽环类药物和多西他赛的辅助化疗:国际乳腺癌研究组02-98随机试验
J Natl Cancer Inst. 2008 Jan 16;100(2):121-33. doi: 10.1093/jnci/djm287. Epub 2008 Jan 8.
9
Pharmacokinetics and safety of cyclophosphamide and docetaxel in a hemodialysis patient with early stage breast cancer: a case report.环磷酰胺和多西他赛在一名早期乳腺癌血液透析患者中的药代动力学及安全性:病例报告
BMC Cancer. 2015 Nov 18;15:917. doi: 10.1186/s12885-015-1932-3.
10
Combined chemo- and hormonal therapy in advanced breast cancer.晚期乳腺癌的化疗与激素联合治疗
Cancer. 1977 Jun;39(6 Suppl):2923-33. doi: 10.1002/1097-0142(197706)39:6<2923::aid-cncr2820390679>3.0.co;2-3.

引用本文的文献

1
Examination of generational impacts of adolescent chemotherapy: Ifosfamide and potential for epigenetic transgenerational inheritance.青少年化疗的代际影响研究:异环磷酰胺与表观遗传跨代遗传的可能性。
iScience. 2022 Nov 12;25(12):105570. doi: 10.1016/j.isci.2022.105570. eCollection 2022 Dec 22.
2
Therapy-Induced Senescence Drives Bone Loss.治疗诱导衰老导致骨质流失。
Cancer Res. 2020 Mar 1;80(5):1171-1182. doi: 10.1158/0008-5472.CAN-19-2348. Epub 2020 Jan 13.
3
Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance.
有机阴离子转运多肽1A/1B对多柔比星摄取和清除的作用
Mol Pharmacol. 2017 Jan;91(1):14-24. doi: 10.1124/mol.116.105544. Epub 2016 Oct 24.
4
Pharmacokinetics and Pharmacodynamics in Breast Cancer Animal Models.乳腺癌动物模型中的药代动力学与药效学
Methods Mol Biol. 2016;1406:271-87. doi: 10.1007/978-1-4939-3444-7_23.
5
Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study.感知压力水平、化疗、放疗与肿瘤特征与乳腺癌确诊女性体细胞染色体不稳定性频率持续增加有关:一项为期一年的纵向研究。
PLoS One. 2015 Jul 15;10(7):e0133380. doi: 10.1371/journal.pone.0133380. eCollection 2015.
6
Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors.实时成像技术揭示肿瘤中死亡受体的动态变化及克服 TRAIL 耐药性的治疗方法。
Oncogene. 2013 Jun 6;32(23):2818-27. doi: 10.1038/onc.2012.304. Epub 2012 Jul 23.
7
Nano delivers big: designing molecular missiles for cancer therapeutics.纳米传递大:设计用于癌症治疗的分子导弹。
Pharmaceutics. 2011;3(1):34-52. doi: 10.3390/pharmaceutics3010034.
8
Chemotherapy-induced late transgenerational effects in mice.化疗诱导的小鼠迟发性跨代效应。
PLoS One. 2011 Mar 17;6(3):e17877. doi: 10.1371/journal.pone.0017877.